Global Fungal Testing Kit Market Strategic Research Report
By Type: ELISA, Colloidal Gold Immunochromatography, other
By Application: Testing Facility, Manufacturer, Research and Academic Institutions, Other
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: DSM, Charm, Neogen, PerkinElmer, Unisensor, Eurofins Scientific, EnviroLogix, Merck KGaA, Yirui Biology, Qinbang Biology, Food Safety Technology, Dean Bio, Sino-German Biology, Widowikon
Overzicht
Scope of the Report
The global Fungal Testing Kit market size is predicted to grow from US$ 663 million in 2025 to US$ 1,109 million in 2032; it is expected to grow at a CAGR of 7.7% from 2026 to 2032.
Fungal Testing Kits for the food industry are analytical tools designed to detect molds, yeasts, and their metabolites (such as mycotoxins) in food products, raw materials, packaging, and environmental samples. These kits employ techniques including immunoassays (ELISA, colloidal gold), molecular diagnostics (PCR, qPCR, LAMP), and confirmatory chromatography-mass spectrometry. They provide qualitative and quantitative analysis of fungal contamination and species identification. Fungal detection is crucial in grains, dairy, fruits, beverages, feed, infant formula, and food processing environments to ensure safety and compliance with regulatory standards (EU, FDA, GB). With the growing emphasis on clean labeling and traceability, fungal testing kits are expanding from laboratory use to on-site and rapid screening applications.In 2024, global Fungal Testing Kits production reached approximately 364.5 m units, with an average global market price of around US$ 1.65 perunit.The average gross profit margin of this product is 70%.
With increasingly stringent food safety regulations, fungal and mycotoxin testing has become a mandatory component of quality control across the food supply chain. Global standards such as aflatoxins, ochratoxin A, and DON have driven adoption of molecular and immunological detection kits among food processors, dairy producers, and grain storage facilities. Developing countries upgrading their export standards also create new opportunities. The rise of portable and automated testing instruments enables real-time contamination control across production lines, integrating fungal detection into smart manufacturing.
Complex sample matrices, long pre-processing times, and high fungal diversity make standardization difficult. Fat-rich or protein-dense foods can interfere with immunoassays or nucleic acid extraction, reducing accuracy. Traditional culture-based methods remain dominant in some markets, delaying adoption of high-sensitivity molecular kits. Cost constraints and inconsistent regulatory harmonization across regions pose additional barriers for suppliers.
Food manufacturers are shifting from reactive testing to preventive, real-time monitoring. Grain, beverage, and meat processors are deploying on-site molecular kits integrated with digital monitoring systems. Premium brands emphasize raw material traceability testing, while small and medium producers favor low-cost, easy-to-use lateral flow and LAMP kits. Export-driven compliance testing aligned with EU and FDA standards is becoming a major growth driver for certified assay kits.
Key materials for fungal testing kits in the food sector include specific antigens/antibodies, PCR primers and probes, enzymes, buffer systems, and adsorptive carriers. The specificity of antibodies determines sensitivity and cross-reactivity performance. Sample processing materials such as spin filters and DNA extraction columns are crucial for reliability. Upstream supply is concentrated in molecular biology and bioengineering firms, with high-purity proteins and lyophilized buffer systems still largely imported.
This report presents a comprehensive overview of the global Fungal Testing Kit market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- ELISA
- Colloidal Gold Immunochromatography
- other
Segment by Product Format
- Mold Testing Kit
- Yeast Testing Kit
- Mycotoxin Testing Kit
- Other
Segment by Application
- Testing Facility
- Manufacturer
- Research and Academic Institutions
- Other
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Fungal Testing Kit market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Testing Facility, Manufacturer, Research and Academic Institutions evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Fungal Testing Kit Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 ELISA
- 3.1.3 Colloidal Gold Immunochromatography
- 3.1.4 other
- 3.1.5 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Testing Facility
- 4.1.3 Manufacturer
- 4.1.4 Research and Academic Institutions
- 4.1.5 Other
- 4.1.6 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 DSM
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Charm
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Neogen
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 PerkinElmer
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Unisensor
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Eurofins Scientific
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 EnviroLogix
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Merck KGaA
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Yirui Biology
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Qinbang Biology
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Food Safety Technology
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Dean Bio
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Sino-German Biology
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 Widowikon
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the current global Fungal Testing Kit market size?
What growth rate is expected for the Fungal Testing Kit market through 2032?
How is Fungal Testing Kit defined?
What are the main segments of the Fungal Testing Kit market by type?
Which applications drive demand in the Fungal Testing Kit market?
Who are the key players in the Fungal Testing Kit market?
Which regions and countries are covered for Fungal Testing Kit?
What is driving growth in the Fungal Testing Kit market?
What challenges does the Fungal Testing Kit market face?
Who should buy the Fungal Testing Kit market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Fungal Testing Kit Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Healthcare & Medical Devices